Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia

Table 1

Baseline demographic and virological parameters of the study cohort.

	Roma	Non-Roma
Count	43	46
Age (years ± SD)	33 ± 8.3	35 ± 7.5	0.081
Women	11 (25.6%)	13 (28.3%)	0.680
HBeAg posit	9 (20.9%)	4 (8.7%)	0.093
HBV DNA IU/mL (median(IQR))	40900 (28900–588000)	27550 (3300–223367)	0.025
HBV DNA < 2000 IU/mL	3 (9.3%)	7 (15.2%)	0.219
ALT > 2 ULN	22 (51.2%)	21 (45.7%)	0.603
Staging (Metavir)	1.64 ± 1.07	1.34 ± 1.04	0.382
Grading (Metavir)	1.91 ± 0.87	2.0 ± 0.76	0.795
Cirrhosis	3 (7.0%)	5 (10.9%)	0.521

ALT: alanine aminotransferase.